RareMe Shaqada Koowaad: Barnaamij Mobile ah oo uu sameeyey Cong Fang, Shijian Luo and Jingzhao Pan

Naqshadda RareMe Shaqada Koowaad: Barnaamij Mobile ah oo uu sameeyey Cong Fang, Shijian Luo and Jingzhao Pan waa mid aad u sharaf badan oo ku guulaysatay tartanka qaybta Naqshadeynta Tiknoolajiyada Moobiilka, Abikaasyoonada iyo Softweyrka ee 2021 Abaalmarinta Naxaasta ah ee A' Design Award.

NaxaasMoobiil· 2021

RareMe Shaqada Koowaad: Barnaamij Mobile ah

Cong Fang, Shijian Luo and Jingzhao Pan uu sameeyay

Macmiilka: Zhejiang University

Ku Guuleystaha Abaalmarinta Naxaasta ah ee A' Design Award ee Qaybta Moobiil

16,439

Ku Guuleystaha Abaalmarinta La Xaqiijiyey

Xaqiiji Xaaladda Abaalmarinta #111937

Ka Eeg A' Design Award War-saxaafadeed Calaamadda Abaalmarinta

Midabada

Naqshadeynta

Wax ku saabsan RareMe Shaqada Koowaad: Barnaamij Mobile ah

Qoraalka Buugga: RareMe waa barnaamij mobile ah oo loogu talagalay dadka ay saameeyaan cudurrada naadirka ah. RareMe waxay ku xiraysaa bukaannada iyo qoysaskooda cisbitaallada, machadyada caafimaadka, farmashiyaha, dhakhaatiirta iyo horumariyayaasha daawooyinka. Isticmaalayaasha waxay dooranayaan doorka ay ku diiwaan gelayaan, ha ahaado bukaan, xubin qoys ah, ama bixiye adeeg caafimaad. Bukaannada waxay ku qori karaan buug-yaraale ku saabsan daaweyntooda, waxay raadin karaan daawooyin iyo daaweyno adduunka oo dhan, waxayna heli karaan isticmaalayaal kale oo leh xaalado la mid ah iyagoo isticmaalaya alogoritham talo-bixin ah. Barnaamijku wuxuu ku shaqeeyaa nidaamyada iOS iyo Android. Ujeeddadu waa in la siiyo bukaannada cudurrada naadirka ah dayacnaan iyo daryeel siman.

Aqoonsiga

Wax ku saabsan Abaalmarinta Naxaasta ah ee A' Design Award

RareMe Shaqada Koowaad: Barnaamij Mobile ah waa guuleystaha Abaalmarinta Naxaasta ah ee A' Design Award, aqoonsi sharaf sare leh oo la siiyo naqshado aan caadi ahayn oo lagu garto hal-abuur, hal-abuur cusub iyo caqli. Guuleystayaasha Naxaasta waa shaqooyin xirfad buuxda leh iyo hal-abuur yaab leh oo xaqiijiya khibrad weyn, male-awaal iyo kartida naqshadeeyayaashooda. RareMe Shaqada Koowaad: Barnaamij Mobile ah waa walax la filayo inay noqoto mid aad loo tixgeliyo, la ixtiraamo oo la jecel yahay, xirfad cad leh oo hal-abuur cusub leh. Naqshadahan ku guuleystay Abaalmarinta Naxaasta ah ee A' Design Award wuxuu ku darsadaa hab-dhaqanno ugu wanaagsan farshaxanka, sayniska, naqshadaynta iyo tignoolajiyada wuxuuna ku fiican yahay dhawrista tafaasiisha. RareMe Shaqada Koowaad: Barnaamij Mobile ah si fiican ayay u buuxisaa baahiyaha, taabataa rabitaannada, soo jiidataa dareenka kicinayaanna xiisaha aqoonta.

Gadaasha Naqshadeynta

Xirmada Warbaahinta

Shahaadooyinka, xubnaha kooxda iyo faahfaahinta farsamada ee uu bixiyay naqshadeeluhu.

Sifooyinka Gaarka ah: Rare diseases are currently affecting about 300 million patients worldwide. Due to their rare conditions, they cannot get the same degree of treatment and assistance as normal patients, especially in some developing countries. RareMe helps rare diseases patients with their recovery and therapy. By connecting with global medical research, institutions, hospitals, doctors, and drug developers, they can receive equal attention and care.
Cabbirka & Qaabaynta: Launched on IOS and Android
Summado: Rare Disease, app, patients, crowd-funding, mutual aid
Tiknoloojiyada Soo Saarka: RareMe is an APP,which connects patients and their families with health-care providers, such as hospitals, medical institutions, pharmacies, doctors, drug developers, pharmaceuticals companies, etc. It also links rare disease patients with similar conditions with medical workers through intelligent recommendation algorithm, so as to make them feel not alone.
Caqabadda Naqshadda: RareMe connects patients and their families with health-care providers, such as hospitals, medical institutions, pharmacies, doctors, drug developers, pharmaceuticals companies, etc.

The biggest problem is to contact all stakeholders, promote app through hospitals, medical institutions, and major media platforms, so that patients scattered around the world can know and join RareMe. With the help of a large number of patients gathering to solve the problem of drug research and distribution by low-cost crowdfunding.
Cilmi-baadhis: Rare diseases are currently affecting 3.5% - 5.9% of the worldwide population. There are more than 7,000 rare diseases known in the world, however, only less than 10% of the diseases have approved treatment drugs or programs.

Based on this huge social problem, we have conducted extensive interviews with medical professors of Harvard University and Medical Laboratory of Zhejiang University, and are eager to connect rare disease patients around the world in a simple and portable way. We have connected many medical workers and patients via the development of RareMe. In order to improve this current condition, we will add in more and more health-care providers in the future.
Dhiirrigelinta: Rare diseases are lately affecting 3.5% - 5.9% of the worldwide population. More than 7,000 rare diseases are known, however, only less than 10% have approved treatment cures or programs. Due to the patients’ rare conditions, they’re not able to get the same degree of care and assistance as normal patients. Moreover, proper medicines and treatments are not available in some developing countries. They have few wardmates to communicate with, either.
Muddada Mashruuca: This project started in September 2019 in Hangzhou, China, and it is still under developing.
Socodka Hawlgalka: At the beginning of registration, user will choose their own role as patients/family members or health-care providers, then enter the home page. Patients can write disease fighting diaries, seek for other users who have similar syndromes and fight together. They can also seek drugs and treatments around the world. As for health-care providers, they can contact patients quickly via RareMe and offer help.
Xubnaha Kooxda: Cong Fang
Shijian Luo
Jingzhao Pan
Tianhe Zhang
Huan Lin
Amaanta Sawirrada: The four images used in the app design are from the SHETU website(https://699pic.com/), and have been authorized. The authorization agreement is shown in the link
Link: https://pan.baidu.com/s/1-s5VTAN_XWqHc2ZyToIegQ
Password：70bo